Search research articles
Contact Us
Filters
Showing results (111-120 of 124) with videos related to
Page
of 13
Sort By:
Journal of Pharmaceutical Sciences
|
May 23, 2023
Clustering of Tadalafil API Samples According to their Manufacturer in the Context of API Falsification Detection
E Deconinck, M Raimondo, A Borioni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques
J L Harousseau, B Witz, B Lioure, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 31, 2004
Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia
J-F Rossi, A van Hoof, K de Boeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Groupe Coopératif Macroglobulinémie
V Leblond, T Ben-Othman, E Deconinck, et al.
Blood
|
January 3, 2001
Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation
P Colombat, G Salles, N Brousse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2000
Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation
I Yakoub-Agha, P de La Salmonière, P Ribaud, et al.
Journal of Internal Medicine
|
December 8, 2017
Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia
C Craddock, J Versluis, M Labopin, et al.
Blood
|
August 10, 1999
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group
P Fenaux, C Chastang, S Chevret, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 13, 2011
Double reduced-intensity allogeneic hematopoietic stem cell transplantation: a retrospective study from the SFGM-TC
J O Bay, A Cabrespine, C Faucher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2017
Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
A Le Bourgeois, M Labopin, D Blaise, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 124) with videos related to
Sort By:
Page
of 13
Journal of Pharmaceutical Sciences
|
May 23, 2023
Clustering of Tadalafil API Samples According to their Manufacturer in the Context of API Falsification Detection
E Deconinck, M Raimondo, A Borioni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques
J L Harousseau, B Witz, B Lioure, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 31, 2004
Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia
J-F Rossi, A van Hoof, K de Boeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Groupe Coopératif Macroglobulinémie
V Leblond, T Ben-Othman, E Deconinck, et al.
Blood
|
January 3, 2001
Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation
P Colombat, G Salles, N Brousse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2000
Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation
I Yakoub-Agha, P de La Salmonière, P Ribaud, et al.
Journal of Internal Medicine
|
December 8, 2017
Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia
C Craddock, J Versluis, M Labopin, et al.
Blood
|
August 10, 1999
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group
P Fenaux, C Chastang, S Chevret, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 13, 2011
Double reduced-intensity allogeneic hematopoietic stem cell transplantation: a retrospective study from the SFGM-TC
J O Bay, A Cabrespine, C Faucher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2017
Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire
A Le Bourgeois, M Labopin, D Blaise, et al.
Page
of 13